The landscape of dementia prognosis has developed significantly with the arrival of subtle biomarkers, such as amyloid PET scans, tau imaging, and blood-based mostly assessments which can detect Alzheimer's pathology many years just before signs or symptoms arise. Though these technological advances signify exceptional progress in comprehension neu